compound 16 [PMID: 31525966]   Click here for help

GtoPdb Ligand ID: 10501

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 16 inhibits the cytolytic pore-forming activity of the perforin 1 protein [2]. It has been developed to ascertain whether perforin inhibition can prevent early rejection of mismatched grafts in donor stem cell transplant procedures, and thereby improve successful engraftment. The acting hypothesis is based on the recognition that the natural killer (NK) cells that drive graft rejection overwhelmingly use perforin to kill non-self targets [1,3]. In addition, as these NK cells are resistant to radio- and immuno-suppression, an alternative mechanism is needed to limit their activity and to achieve clinical efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 138.11
Molecular weight 528.07
XLogP 3.07
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc(s1)c1cnc2c(c1)CN(C2=O)C
Isomeric SMILES COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc(s1)c1cnc2c(c1)CN(C2=O)C
InChI InChI=1S/C24H18F2N4O4S2/c1-30-12-15-7-13(10-27-22(15)24(30)31)19-4-5-20(35-19)14-8-18(23(34-2)28-11-14)29-36(32,33)21-6-3-16(25)9-17(21)26/h3-11,29H,12H2,1-2H3
InChI Key ZYYGNLSPUWSHQW-UHFFFAOYSA-N
Immunopharmacology Comments
Compound 16 has been used to show that (short-term) inhibition of perforin 1 function produces an anti-rejection effect in an in vivo allogeneic bone marrow transplant model [2]. By preventing perforin pore formation, compound 16 reduces the cytolytic capacity of cytotoxic T cells and nautral killer cells, that would otherwise be activated to remove the non-self transplanted cells.